Literature DB >> 12791243

Influence of age and purpose for testing on the cut-off selection of serological methods in bovine neosporosis.

Gema Alvarez-García1, Esther Collantes-Fernández, Eduardo Costas, Xabier Rebordosa, Luis Miguel Ortega-Mora.   

Abstract

The aim of this study was to investigate the need for different cut-off points, according to animal age and the purpose of testing, for two of the most widely used serological techniques in bovine neosporosis, IFAT and a crude antigen ELISA (Civtest, HIPRA). Therefore, the population reference sera used were defined using a combination of multiple criteria such as epidemiological/clinical and histopathological parameters and an immunoblot test. Firstly, foetuses and breeding cattle (heifers and cows) were considered as separate subpopulations for serological evaluation. Secondly, cut-off points for each serological technique (IFAT and ELISA) according to age group (foetuses and breeding cattle) and the different practical applications (detection of infection and abortion) were calculated following the receiver operating characteristics (ROC) analysis. Cut-off points were defined, for IFAT and ELISA for aborted breeding cattle and for IFAT alone in the case of the foetuses, assuming an equivalent cost of false positive and negative results. In infected breeding cattle, for IFAT and ELISA and in foetuses for ELISA, two possible cut-off values were obtained, one for a maximum sensitivity and one for a maximum specificity and the intervals of unclear results were defined. In this case, a cut-off value for equal sensitivity and specificity was also estimated. When cut-off points for infected breeding cattle, 1:100-1:250 for IFAT and 0.306-0.451 for ELISA were applied to a target population, optimal and similar negative and positive predictive values together with similar apparent and true prevalence results were observed suggesting the possibility of using both tests interchangeably.

Entities:  

Mesh:

Year:  2003        PMID: 12791243     DOI: 10.1051/vetres:2003009

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  24 in total

1.  An Ibero-American inter-laboratory trial to evaluate serological tests for the detection of anti-Neospora caninum antibodies in cattle.

Authors:  Lucía M Campero; Javier Moreno-Gonzalo; María C Venturini; Gastón Moré; Andrea Dellarupe; Magdalena Rambeaud; Ignacio E Echaide; Beatriz Valentini; Carlos M Campero; Dadín P Moore; Dora B Cano; Marcelo Fort; Rinaldo A Mota; Marcos E Serrano-Martínez; Carlos Cruz-Vázquez; Luis M Ortega-Mora; Gema Álvarez-García
Journal:  Trop Anim Health Prod       Date:  2017-09-16       Impact factor: 1.559

2.  Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy.

Authors:  Roberto Sánchez-Sánchez; Ignacio Ferre; Michela Re; Juan José Ramos; Javier Regidor-Cerrillo; Manuel Pizarro Díaz; Marta González-Huecas; Enrique Tabanera; Julio Benavides; Andrew Hemphill; Matthew A Hulverson; Lynn K Barrett; Ryan Choi; Grant R Whitman; Kayode K Ojo; Wesley C Van Voorhis; Luis Miguel Ortega-Mora
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

Review 3.  Epidemiology and control of neosporosis and Neospora caninum.

Authors:  J P Dubey; G Schares; L M Ortega-Mora
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

4.  An evaluation of common methods for dichotomization of continuous variables to discriminate disease status.

Authors:  Sybil L Prince Nelson; Viswanathan Ramakrishnan; Paul J Nietert; Diane L Kamen; Paula S Ramos; Bethany J Wolf
Journal:  Commun Stat Theory Methods       Date:  2017-08-02       Impact factor: 0.893

5.  Neospora caninum infection as a cause of reproductive failure in a sheep flock.

Authors:  Marta González-Warleta; José Antonio Castro-Hermida; Javier Regidor-Cerrillo; Julio Benavides; Gema Álvarez-García; Miguel Fuertes; Luis Miguel Ortega-Mora; Mercedes Mezo
Journal:  Vet Res       Date:  2014-08-26       Impact factor: 3.683

6.  Experimental infection with a low virulence isolate of Neospora caninum at 70 days gestation in cattle did not result in foetopathy.

Authors:  Silvia Rojo-Montejo; Esther Collantes-Fernández; Javier Blanco-Murcia; Antonio Rodríguez-Bertos; Verónica Risco-Castillo; Luis Miguel Ortega-Mora
Journal:  Vet Res       Date:  2009-06-06       Impact factor: 3.683

7.  Maternal and Foetal Cellular Immune Responses in Dams Infected With High- and Low- Virulence Isolates of Neospora caninum at Mid-Gestation.

Authors:  Marta García-Sánchez; Laura Jiménez-Pelayo; Patricia Vázquez; Pilar Horcajo; Javier Regidor-Cerrillo; Alejandro Jiménez-Meléndez; Koldo Osoro; Luis Miguel Ortega-Mora; Esther Collantes-Fernández
Journal:  Front Cell Infect Microbiol       Date:  2021-06-22       Impact factor: 5.293

8.  Identification of molecular biomarkers associated with disease progression in the testis of bulls infected with Besnoitia besnoiti.

Authors:  David González-Barrio; Carlos Diezma-Díaz; Daniel Gutiérrez-Expósito; Enrique Tabanera; Alejandro Jiménez-Meléndez; Manuel Pizarro; Marta González-Huecas; Ignacio Ferre; Luis M Ortega-Mora; Gema Álvarez-García
Journal:  Vet Res       Date:  2021-07-22       Impact factor: 3.683

9.  Neospora caninum infection during early pregnancy in cattle: how the isolate influences infection dynamics, clinical outcome and peripheral and local immune responses.

Authors:  Javier Regidor-Cerrillo; David Arranz-Solís; Julio Benavides; Mercedes Gómez-Bautista; José Antonio Castro-Hermida; Mercedes Mezo; Valentín Pérez; Luis Miguel Ortega-Mora; Marta González-Warleta
Journal:  Vet Res       Date:  2014-01-30       Impact factor: 3.683

10.  Effect of vaccination of cattle with the low virulence Nc-Spain 1H isolate of Neospora caninum against a heterologous challenge in early and mid-gestation.

Authors:  Silvia Rojo-Montejo; Esther Collantes-Fernández; Francisco Pérez-Zaballos; Sonia Rodríguez-Marcos; Javier Blanco-Murcia; Antonio Rodríguez-Bertos; Antoni Prenafeta; Luis Miguel Ortega-Mora
Journal:  Vet Res       Date:  2013-11-01       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.